Ladder Bio Inc.
United States
- Blue Bell, PA
- 13/11/2025
- Seed
- $5,500,000
Ladder Bio (formerly ThirdLaw Molecular) has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of Ladder Bio is to create a revolutionary category of molecules that transform how diseases are diagnosed and treated – more safely and effectively.
- Industry Biotechnology Research
- Website https://ladderbio.com/
- LinkedIn https://www.linkedin.com/company/thirdlaw-llc/
Related People
Eric HeilFounder
United States -
Doylestown, Pennsylvania
With nearly 20 years of experience in healthcare venture capital and entrepreneurship, I am a Managing Partner at Medical Excellence Capital (MEC), an early-stage life science venture fund that leverages a global network of medical experts, family offices, and academic institutions to invest in innovative and impactful biotech and precision health technologies.
I have personally co-founded, launched, and led several successful healthcare companies, including RightCare Solutions, a digital health company that was acquired by naviHealth, and Upward Health, a tech-enabled care delivery service for complex patients. Cofounded ProJenX, an neurogenerative company, and helped launch Ladder Bio. I have also served as a board member, board observer, advisor, and executive for multiple venture-backed companies, such as Ladder Bio, ProJenX, Nobias Therapeutics, GC Therapeutics, and others.
I am passionate about improving the U.S. healthcare system collaboratively with innovative life science technologies, value-oriented care delivery strategies, and evidence-based solutions that make a positive difference for patients. I am driven by the desire to positively impact patients and to be part of a team-based culture committed to collaborating with passionate and dedicated innovators, financiers, and strategic partners. I am also a former adjunct professor and co-instructor of healthcare entrepreneurship at the Wharton School, where I earned my MBA, and I also hold a BSE in Systems Engineering and Healthcare Systems from the University of Pennsylvania.
A dedicated husband/father of a blended family with five great kids!
Valinor | $13,000,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
conveyd | $3,345,837 | (Dec 12, 2025)
Ritten | $35,000,000 | (Dec 12, 2025)
Safebooks AI | $15,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Yonda | $15,000,000 | (Dec 12, 2025)
Medra | $52,000,000 | (Dec 12, 2025)
Cynch AI | $9,000,000 | (Dec 12, 2025)
Empromptu.ai | $2,000,000 | (Dec 11, 2025)